Obstetrics & Gynecology · Midland, TX
NPI
1215948450
Since 2006
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
2500 West Illinos, Suite 100
Midland, TX, 79701
Phone (432) 699-2370
Groups this clinician bills Medicare through
Medicare paid, 2024
$84K
2,993 services
Medicare patients, 2024
183
Average age 73
Drug cost, 2024
$60K
790 prescriptions
Company payments, 2025
$370
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ben W Doke was code J0897 (injection, denosumab, 1 mg), 1,680 times for 17 patients. In total Ben W Doke billed 2,993 services in 60 codes, and Medicare paid $84K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-03-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,680 | 17 | $19.77 | $33K |
| 99214 Office E&M - Established | Office | 116 | 98 | $74.36 | $8,626 |
| 96127 Behavioral Health Services | Office | 91 | 46 | $3.24 | $295 |
| 85025 Blood Count | Office | 79 | 71 | $7.51 | $594 |
| 80076 Clinical Chemistry | Office | 79 | 72 | $8.01 | $633 |
| 80061 Clinical Chemistry | Office | 78 | 70 | $13.12 | $1,023 |
| 80048 Clinical Chemistry | Office | 76 | 70 | $8.29 | $630 |
| 77063 Mammography | Office | 73 | 73 | $49.29 | $3,598 |
| 77067 Mammography | Office | 73 | 73 | $120.04 | $8,763 |
| 81001 Clinical Chemistry | Office | 69 | 54 | $3.11 | $215 |
| 81015 Clinical Chemistry | Office | 68 | 57 | $2.99 | $203 |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 56 | 56 | $37.34 | $2,091 |
| 84443 Clinical Chemistry | Office | 53 | 50 | $16.46 | $872 |
| 84439 Clinical Chemistry | Office | 53 | 50 | $8.84 | $469 |
| 84481 Clinical Chemistry | Office | 51 | 48 | $16.60 | $847 |
By year: 2022 $56K for 1,957 services; 2023 $69K for 2,221 services; 2024 $84K for 2,993 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 79 | 71 | $7.51 | $594 |
| 80076 Clinical Chemistry | 79 | 72 | $8.01 | $633 |
| 80061 Clinical Chemistry | 78 | 70 | $13.12 | $1,023 |
| 80048 Clinical Chemistry | 76 | 70 | $8.29 | $630 |
| 81001 Clinical Chemistry | 69 | 54 | $3.11 | $215 |
| 81015 Clinical Chemistry | 68 | 57 | $2.99 | $203 |
| 84439 Clinical Chemistry | 53 | 50 | $8.84 | $469 |
| 84443 Clinical Chemistry | 53 | 50 | $16.46 | $872 |
| 84481 Clinical Chemistry | 51 | 48 | $16.60 | $847 |
| 83036 Blood Count | 46 | 44 | $9.52 | $438 |
Medicare prescription drug claims, 2024
In 2024, the drug Ben W Doke prescribed most often to Medicare patients was Levothyroxine Sodium, with 90 prescriptions and refills. In total Ben W Doke wrote 790 Medicare prescriptions that cost $60K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 90 | 220 | 22 | $1,160 |
| Estradiol Generic | 50 | 131 | 21 | $2,063 |
| Rosuvastatin Calcium Generic | 49 | 93 | 12 | $268 |
| Atorvastatin Calcium Generic | 31 | 79 | Under 11 | $329 |
| Solifenacin Succinate Generic | 29 | 59 | 12 | $1,833 |
| Escitalopram Oxalate Generic | 29 | 46 | Under 11 | $300 |
| Pantoprazole Sodium Generic | 28 | 38 | Under 11 | $156 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 27 | 27 | 21 | $454 |
| Simvastatin Generic | 24 | 72 | Under 11 | $104 |
| Amlodipine Besylate Generic | 22 | 62 | Under 11 | $278 |
| Myrbetriq Mirabegron | 21 | 37 | Under 11 | $15K |
| Montelukast Sodium Generic | 21 | 29 | Under 11 | $78.93 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 14 | 14 | 13 | $40.34 |
| Isibloom Desogestrel-Ethinyl Estradiol | 14 | 14 | Under 11 | $249 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 13 | 35 | Under 11 | $280 |
Brand drugs: 106 claims; generic drugs: 684 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ben W Doke $370 ($370 in general payments such as food, travel and fees) from 10 companies. The largest payer was Biogen, Inc. with $142.
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. BIIB | 6 | $142 |
| Radius Health, Inc. | 3 | $70.87 |
| Pacira Pharmaceuticals Incorporated PCRX | 1 | $34.05 |
| Sumitomo Pharma America, Inc. 4506.T | 1 | $22.77 |
| Boston Scientific Corporation BSX | 1 | $18.64 |
| Shield Therapeutics Inc STX.L | 1 | $18.42 |
| Organon LLC OGN | 1 | $18.16 |
| Lilly USA, LLC LLY | 1 | $16.63 |
| Astellas Pharma US Inc 4503.T | 1 | $14.82 |
| Amgen Inc. AMGN | 1 | $13.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.